{
    "clinical_study": {
        "@rank": "93937", 
        "arm_group": {
            "arm_group_label": "Female patients diagnosed with metastatic breast cancer", 
            "description": "Patients newly diagnosed with metastatic breast cancer, either De Novo or having progressed from a non-metastatic stage."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the incidence rate of progression of disease, to\n      describe the diagnostic and clinical management  in patients with Metastatic Breast Cancer\n      in the clinical practice in Bulgaria."
        }, 
        "brief_title": "Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Metastatic Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in\n      Clinical Practice in Bulgaria"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  New diagnosis of breast cancer according to ICD-10 with confirmed metastasis\n\n          -  Confirmed diagnosis between 1st July 2010 and 30th June 2011.\n\n          -  Female patient managed for her disease at the same setting where final diagnosis of\n             MBC was performed.\n\n        Exclusion Criteria:\n\n          -  History of concurrent or other primary malignancies (except curatively resected\n             non-melanoma skin cancer or in situ cervical cancer)."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients newly diagnosed with breast cancer (according to ICD-10) with confirmed\n        metastasis, regardless of being de novo diagnosed or progressed from a non-metastatic\n        stage."
            }
        }, 
        "enrollment": {
            "#text": "171", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01715155", 
            "org_study_id": "NIS-OBG-XXX-2012/1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Metastatic Breast Cancer,", 
            "retrospective study,", 
            "disease progression,", 
            "clinical management"
        ], 
        "lastchanged_date": "August 21, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Pleven", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plovdiv", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ruse", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stara Zagora", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varna", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Reaseach Site"
                }
            }
        ], 
        "location_countries": {
            "country": "Bulgaria"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Bulgaria: Bulgarian Drug Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of progression events on a per patient-year-basis", 
            "safety_issue": "No", 
            "time_frame": "Up to 2 years 5 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01715155"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion of patients among study population who have not progressed at 12 and 18 months after they were diagnosed", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years 5 months"
            }, 
            {
                "measure": "Median and mean time interval that elapsed between diagnosis and first objective tumor progression (TTP) event and subsequent events", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years 5 months"
            }, 
            {
                "measure": "Median and mean time from the date of diagnosis to the date of breast cancer progression or death whichever occurred first", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years 5 months"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}